Poland· PL-100504640
Akantior
A polihexanide product containing polihexanidum, registered in Poland by SIFI S.p. A.. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Polihexanide is registered in 9 of 19 countries.
Countries holding a registration under ATC S01AX24 (polihexanide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Polihexanide · ATC S01AX24
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Polihexanidum
- Manufacturer
- SIFI S.p. A.
- Country
- Poland (PL)
- ATC code
- S01AX24
- ATC class
- Polihexanide
- Defined daily dose
- 4 Eindosisbeh
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991555313
- gtin08027864000580
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Polihexanide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAkantior 0.08% eye drops 0.3ml unit doseImported (Italy)
- SwitzerlandLavasept, gebrauchsfertige VerdünnungB. Braun Medical AG
- CzechiaAKANTIORSIFI S.P.A., ACI SANT'ANTONIO (CT)
- IrelandAKANTIOR 0.8 mg/mL eye drops, solution in single-dose containerSIFI S.p.A.
- IcelandAKANTIORSIFI S.p.A.
- NetherlandsAKANTIOR 0,8 mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruikSIFI SpA
- BelgiumAkantior 0.8 mg/mlSIFI
- SwedenAKANTIOR 0,8 mg/ml Ögondroppar, lösning i endosbehållareSIFI S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Akantior
- Norway · Akantior
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6f467f3-dd85-45b3-aa02-3a90e464a577 GET /v1/drugs/e6f467f3-dd85-45b3-aa02-3a90e464a577?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór w pojemniku jednodawkowym",
"source": "urpl",
"strength": "0,8 mg",
"packaging": "Rpz ¦ EU/1/24/1840/001 ¦ 157802\n20 poj. jednodawkowych 0,3 ml\n05909991555313 ¦ Rpz ¦ Skasowane ¦ EU/1/24/1840/002 ¦ 157803\n30 poj. jednodawkowych 0,3 ml\nRpz ¦ EU/1/24/1840/003 ¦ 157804\n120 poj. jednodawkowych 0,3 ml (op. zbiorcze)\n08027864000580 ¦ Rpz ¦ EU/1/24/1840/002 ¦ 158202\n30 poj. jednodawkowych 0,3 ml",
"substance": "Polihexanidum 0.8 mg",
"common_name": "Polihexanidum",
"pl_product_id": "100504640",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about polihexanide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.